We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
ASX hits record high with tech stocks leading TechnologyOne shares soar after strong earnings resul...
Read ArticleASX rises, but MinRes drops over transparency issues Fed boss Powell’s cautious rate cut stance coo...
Read ArticleASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results...
Read ArticleThe S&P/ASX 200 fell 1.3% in October with small cap companies outperforming S&P Dow Jones I...
Read ArticleASX opens November lower, led by financial sector sell-off Macquarie Group fell after profit decli...
Read ArticleASX slips amid earnings updates and company meetings AGL drops over 6pc after downgrade, while...
Read ArticleASX slumps heavily after inflation data Australian inflation drops to 2.8pc, lower than expected...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highligh...
Read ArticleASX edges slightly up by 0.12pc as traders rethink rate cuts Consumer staples shine while gold min...
Read ArticleThe ASX fell on new expectations for rate cuts All 11 ASX sectors fell, with real estate and hea...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highligh...
Read ArticleASX 200 hits record highs fuelled by Wall Street rally Tech and iron ore stocks lead gains Tyro...
Read ArticleHighlights ASX 200 hits new record as InfoTech and Telcos lead early trading. Crude oil weaknes...
Read ArticleASX fell as mining stocks dropped on China’s lack of stimulus Brent oil dipped below US$80 Big lit...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at somewhere near 11-ish, which is meant to highligh...
Read ArticleASX rises as banking and tech sectors lead gains Arcadium Lithium surges on potential acquisition...
Read ArticleHealthcare stocks are doing relatively well globally in 2024 The sector could see more recovery as...
Read ArticleASX rises modestly with mining stocks leading gains Fortescue surges nearly 5pc as iron ore pric...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highligh...
Read ArticleRecent updates highlight significant strides in the biopharmaceutical sector. Paradigm Biopharmaceut...
Read ArticleASX slips after hitting new high ahead of Fed decision Iron ore prices expected to drop below US...
Read ArticleLife sciences group Invion (ASX: IVX) has announced that its photodynamic technology (PDT) partner R...
Read ArticleHealth Check (briefly called Alive and Kicking before we grew tired of the Simple Minds tune running...
Read ArticleAlive and Kicking is renowned biotech journo Tim Boreham’s new daily wrap covering morning movers an...
Read ArticleASX falls on Wednesday with banks dragging down market Lithium stocks surge on CATL suspension r...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highligh...
Read ArticleASX closes higher as CBA and Macquarie touch records Lotus Resources finds significant uranium; go...
Read ArticleASX slips as US jobs data fuels Wall Street panic Westpac gets a new CEO Newcomers into the ASX...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highligh...
Read ArticleASX up on Thursday, tech stocks rise boosted by NextDC Wodside Energy drops due to downgrade and o...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highligh...
Read ArticleASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing;...
Read ArticleASX 200 up on Friday boosted by strong US GDP and Wall Street gains Star Entertainment gets scathin...
Read ArticleThe ASX lagged on Thursday after Nvidia’s disappointing Q3 guidance Mineral Resources fell 8pc off...
Read ArticleAussie stocks dropped despite Wall Street edging up ahead of Nvidia’s report Inflation eased to 3.5...
Read ArticleAussie shares rose on Fed rate cut hopes Kelsian plunged, while Kalina, Actinogen and Kogan surged...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highligh...
Read ArticleASX ended 10-day winning streak ANZ, Tabcorp dropped after facing regulators Despite a crude price...
Read ArticleASX up as earnings season rolls on; Origin down 10pc, Telstra up 3pc Australia’s unemployment rate...
Read ArticleThe ASX dropped, dragged down by Real Estate and Mining stocks Qantas cuts former CEO’s compensatio...
Read ArticleS&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expec...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highligh...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highligh...
Read ArticleThe EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-l...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highligh...
Read ArticleASX 200 ends a weak day down but not way down… just -0.23pc All 11 sectors were generally terrible...
Read ArticleIt has been a quiet enough day in terms of news around the market… and in the absence of salacious h...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highligh...
Read ArticleThe ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biot...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highligh...
Read ArticleASX 200 hit by afternoon profit taking, closing at +0.1pc for the day. 9 of 11 ASX sectors were h...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highligh...
Read ArticleASX closes almost 1.4pc higher Broad-based gains Top small cap performers led by Vonex The loc...
Read ArticleASX down 0.5pc, Energy sector up due mainly to Woodside’s upgrade. CRH to acquire Adbri, ending Adb...
Read ArticleS&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biot...
Read ArticleAussie stocks fell 1pc on rising inflation ASX sectors mostly down; IAG hit by class action lawsuit...
Read ArticleASX 200 dips amid Wall Street closure for Memorial Day Commodities bounce back; gold stocks rise,...
Read ArticleStockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) pe...
Read ArticleResearch shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase th...
Read ArticleASX retreats on Tuesday ahead of Fed Budget and US PPI/CPI Copper stocks up after the metal hit hig...
Read ArticleASX losses accelerate after sluggish retail sector updates Baby Bunting, Temple & Webster, JB...
Read ArticleASX rallies, with all sectors rallying on Tuesday The RBA holds rate, but keeps door open for more...
Read ArticleASX Health sector was in correction territory in April Why is the health sector different from othe...
Read ArticleThere’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to c...
Read ArticleStockhead’s Top 10 at 11, published each trading day, highlights the best (and worst) performing ASX...
Read ArticleLocal markets recover early losses to close slightly ahead Material and Financial gains offset IT a...
Read ArticleStockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) pe...
Read ArticleStockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) pe...
Read ArticleASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essenti...
Read ArticleInvion (ASX:IVX) has announced the findings of a study by the Peter MaCallum Cancer Centre o...
Read ArticleThe ASX 200 index has retreated from its all time high levels on Monday after closing -0.15% lower. ...
Read ArticleStockhead’s Top 10 at 11, published each trading day, highlights the best (and worst) performing ASX...
Read ArticleViking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on p...
Read ArticleLocal markets end +0.13% higher in quasi-comeback Consumer Staples soar on bumper Coles news, but...
Read ArticleLocal markets end Friday (and the week) ahead circa 0.4pc IT sector booms 1.5pc Small caps led by...
Read ArticleThe ASX benchmark has ended Wednesday higher after positive inflation data 7 of 11 sectors in the g...
Read ArticleStockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might h...
Read ArticleThe ASX benchmark has ended Thursday in a circa -0.8% hole Energy Sector, down -1.4% leads losses...
Read ArticleXi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for t...
Read ArticleThe ASX has ended Wednesday jumping almost 100 points. Huge effort, everyone Energy Sector misses o...
Read ArticleASX200 closes 0.9pc higher Property stocks and IT sector enjoy huge day Small caps led by DCL Th...
Read ArticleBenchmark ASX index ends +0.21%, but down -2.2% this week Consumer stocks offset Tech losses Small...
Read ArticleNews relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD f...
Read ArticleStockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might h...
Read ArticleL’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supr...
Read ArticleDimerix’s drug granted QYTOVRA as brand name by US FDA Starpharma completes recruitment for VIRALEZ...
Read ArticleAccording to the World Health Organisation (WHO), cancer is the leading cause of death globally. WHO...
Read ArticleThe FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergenc...
Read ArticleStockhead’s Top 10 at shortly-before-11-ish, published shortly after I’ve located my reading glasses...
Read ArticleEarnings reports dominated headlines in August Despite solid results from ASX healthcare giants, th...
Read ArticleASX 200 closes about 0.06% in the green (so, really, we ended in the chartreuse) down -1.2 in Augus...
Read ArticleAustralian biotech has attracted US investments in the last five years Among ASX stocks to get fund...
Read ArticleASX 200 benchmark rises almost 0.6% Tech Sector recovers Wednesday’s losses, after Nasdaq positivit...
Read ArticleBiotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two g...
Read ArticleLocal markets have pedalled furiously since lunch to bring the benchmark to +0.35%. CBA posts recor...
Read ArticleASX benchmark finishes the flat, after struggling to find traction since mid-morning Health Care r...
Read ArticleASX sleepwalks to an underwhelming -0.3% loss for the day. Real Estate the ‘highlight’, on a paltr...
Read ArticleThe end of pandemic and higher rates have subdued biotech market But there are signs now the sector...
Read ArticleThe ASX 200 finishes up 1.56% The ASX XEC rises 1.52% All 11 sectors were higher lead by Real Est...
Read ArticleS&P/ASX 200 closes well in the red today: -1.24% after US stocks dipped on the back of Fed hawk...
Read ArticleS&P/ASX 200 closes in the red today: -0.35%, as US stock markets enjoy a July 4 chilli dog, or...
Read ArticleThe S&P ASX 200 was up 1.76% in June, with large caps performing the best and small caps laggin...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleBrisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “gam...
Read ArticleASX has finished 0.5% ahead, despite Wall Street’s flabby performance on Friday. Health Care has ta...
Read ArticleThe infectious diseases space is one area that could be interesting for ethical investors An ASX co...
Read ArticleSmall cap health stocks are not known to pay dividends But there’s a handful of such stocks on the...
Read ArticleBiotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We...
Read ArticlePfizer said its diabetes drug works as well as Ozempic for weight loss What are the side effects of...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleS&P/ASX 200 closes up 0.40%, while the emerging companies index rises 0.43% Algerian mining reg...
Read ArticleThe Federal Budget delivers billions of dollars funding into healthcare and aged care Mental health...
Read Article‘More of the same’ since lunchtime saw the benchmark land at -0.25% for the day Health Care coughed...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleArtificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discove...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleASX climbed as high as +1.3%, easing slightly to close up 0.9%. XEC Emerging Companies and Goldies...
Read ArticleHighlights Invion has released its H1FY23 report, highlighting progress with respect to its Phot...
Read ArticleHighlights In a recent report and accompanying blog, CSIRO has talked about the threat that supe...
Read ArticleHighlights Photodynamic therapy (PDT) is designed to treat cancer patients using drugs activated...
Read ArticleINOVIQ announced positive results on SUBB2M Invion expands to international markets INOVIQ (ASX:II...
Read ArticleHighlights Invion and RMW Cho Group have executed a conditional agreement for the expansion of e...
Read ArticleThe ASX is set to rise today after a seesaw session on Wall Street Fed Chairman Jerome Powell spoke...
Read ArticleThe FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have g...
Read ArticleHighlights Invion has tabled its December 2022 quarter, highlighting promising research outcomes...
Read ArticleJapanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based devic...
Read ArticleHighlights Invion witnessed successful research outcomes in 2022, laying the groundwork for an e...
Read ArticleHighlights The world needs to focus on developing innovative treatments to be prepared for the n...
Read ArticleASX health stocks have been out of favour this year with rotation away from growth to value sector...
Read ArticleHighlights Invion is going strong with research work focused on cancer and infectious diseases....
Read ArticleWe take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks fr...
Read ArticleHighlights Invion reports that the results of its latest study indicate promise for the Photosof...
Read ArticleBlood clot programs have taken the spotlight recently as new discoveries made Two ASX health stocks...
Read ArticleBenchmark set to end the day down 1.5% Small caps smashed down 4.2% Greenwing up 70% on Chinese inv...
Read ArticleHighlights Invion is riding high on latest study outcomes indicating the effectiveness of its le...
Read ArticleInvion’s lead drug is found to be effective against anal cancer Althea launches new cannabis produc...
Read ArticleInvion (IVX) claims the first set of results from in-vitro lab tests of its INV043 product confirm t...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleHighlights Invion has secured positive screening results from the in vitro study of PhotosoftTM...
Read ArticleInvion’s (IVX) Photosoft compound demonstrates more than 99 per cent inhibition against the Zika vir...
Read ArticleThere’s a new development in the fight against the Zika virus. Invion (ASX:IVX) has just demonstrate...
Read ArticleAussie markets are flat, flat, flat (actually the benchmark found 0.1%) Banks are lower, consumer n...
Read ArticleWhat are the risks of investing in biotechs? How to value a biotech Top 10 crucial trials coming up...
Read ArticleUS FDA approves the first clinical trial using naturally derived psychedelic drugs It could open po...
Read ArticleThe ASX 200 ends ever so slightly up, XEC finds 0.4% Gains in consumer discretionary, tech offset b...
Read ArticleA recent research reveals which biotech segments VCs are ploughing billions of dollars into We list...
Read ArticleHitIQ and Volpara sign major deals in the US ECS Botanics makes first cannabis flower shipment to N...
Read ArticleThe ASX is set to open more than 1% lower today as Wall Street plunges overnight Tech stocks led th...
Read ArticleInvion (IVX) confirms combination therapy of INV043 and immune checkpoint inhibitors (ICI) is more...
Read ArticleInvion demonstrates high efficacy of INV043 when used as a combined therapy Biotron gets positive f...
Read ArticleThe Healthcare sector has been struggling as the pandemic wanes But most money managers are still b...
Read ArticleThe healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak mark...
Read ArticleBiotech sector has had a tough time recently But there are signs of things improving this year A lo...
Read ArticleTelehealth was already a growing space even before the pandemic, but COVID had launched it into the...
Read ArticleThe ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial t...
Read ArticleAt the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, be...
Read ArticleIt’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and...
Read ArticleThe life sciences sector has emerged into the spotlight ever since the pandemic began. In the US, th...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 los...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 los...
Read ArticleLife sciences company Invion (ASX: IVX) is raising $15 million to continue developing the Photosoft...
Read ArticleInvion (IVX) is aiming to raise $15 million in additional capital to help fund the expansion of its...
Read ArticleThe ASX posted steady gains to start the week on Monday, with investors preferences leaning towards...
Read ArticleThe ASX had a positive finish to the week although it is in negative territory for the week. The ASX...
Read ArticleInvion (IVX) ends the week in a trading halt while it plans the details of an upcoming capital rais...
Read ArticleLife sciences outfit Invion is seeking $15 million to expand its technology licences for cancer trea...
Read ArticleAfter a few weeks when the Hot Money column briefly turned into a ‘bizarro Viagold update’, the ASX...
Read ArticleAfter a positive Monday to Thursday, the ASX wiped out gains made across the week, losing more than...
Read ArticleLocal stocks lost ground on Thursday, with minor falls at the big end of town and a slightly steeper...
Read ArticleThe Invion Ltd (ASX: IVX) share price is on the move during late afternoon trade. This comes after...
Read ArticleA pilot proof-of-concept study by life sciences company Invion (ASX: IVX) has shown a complete regre...
Read ArticleLife sciences group Invion Group (ASX: IVX) has progressed the development of its next-generation ph...
Read ArticleSYDNEY, Oct. 16, 2021 /PRNewswire/ — Ensuring healthy lives and promoting physical and mental wel...
Read ArticleWhile Invion Group (ASX: IVX) progresses its next-generation photodynamic therapy INV043 for treatin...
Read ArticleLife sciences company Invion Group (ASX: IVX) is rapidly advancing its next-generation photodynamic...
Read ArticleAlthough earnings results were the main theme in August, there were also some notable healthcare bre...
Read ArticleOn the back of promising proof-of-concept results on a range of cancers, Invion Group (ASX: IVX) is...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 7...
Read ArticleThe ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the...
Read ArticleThe armed forces could be called upon to enforce Sydney’s strict lockdown, and we might see troops o...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 7...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has ret...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading d...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleLast month, the ASX finally reached its pre-pandemic high, went in circles for a couple of weeks the...
Read ArticleSmall caps have dipped for a second straight day following their seven-day winning streak. The Small...
Read ArticleInvestors will be watching for updates on Traka Resources (ASX:TKL) this week, after the gold explor...
Read ArticleIt was a good day for some of ASX-listed cancer therapy stocks yesterday, with three companies relea...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleSummary Biopharmaceutical company Bionomics Limited will expand its product pipeline for the tre...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks f...
Read ArticleA quick wrap of the ASX’s key winners and losers on Friday, September 4. Data is taken after the mar...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleFrom the bulging file of Nasty Obscure Diseases we present idiopathic intracranial hypertension (IIH...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read Article03 Feb 2020 - A subsidiary of Invion (ASX:IVX), EpiTech Dermal Science, has signed an R&D servic...
Read ArticleWhen US Supreme Court judge Louis Brandeis in 1914 opined that sunlight was the best disinfectant, h...
Read ArticleThe health sector was the most successful sector on the ASX in 2019. Various small caps made several...
Read ArticleInvion (ASX:IVX) may have a new Chinese partner to help get its cosmetics business off the ground. T...
Read ArticleTelecommunications company Uniti Group (ASX:UWL) has topped the list of companies making their debut...
Read ArticleHere’s our monthly wrap of all the news driving ASX health stocks. Of the ASX’s 137-odd small cap he...
Read ArticleSpies defecting, a foreign power secretly taking control of Australia via 5G, the stealthy infiltrat...
Read ArticleAerial imaging firm Aerometrex (ASX:AMX) has had a strong start to listed life on the ASX, notching...
Read ArticleWhile investing in the stock market, an investor comes across various classes of assets, such as equ...
Read ArticleBy the closure of the market session on 29th November 2019, the benchmark index, i.e. S&P/ASX200...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleFor most stocks a double-digit gain in a single day is worthy of celebration. Invion Ltd [ASX:IVX] i...
Read ArticleOne of the best performers on the Australian share market on Wednesday has been the Invion Ltd (ASX...
Read ArticleFor a certain generation of investors the word ‘laser’ is indelibly tied to a Dr Evil reference. Ove...
Read ArticleLife-sciences company Invion (ASX: IVX) has published results from a pre-clinical study that could e...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleMelbourne-based Invion (ASX: IVX) will collaborate with world renowned research organisation Peter M...
Read ArticlePrescient Therapeutics Limited (ASX: PTX) is an Australian clinical stage oncology company that is i...
Read ArticleIt has been a slow start to the new fiscal year, with the list of planned IPOs thinning out. There’s...
Read ArticleBiotech company Invex Therapeutics (ASX:IVX) got off to a flyer when it joined the ASX boards on Fri...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
